{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T18:30:20Z","timestamp":1773340220377,"version":"3.50.1"},"reference-count":30,"publisher":"American Academy of Pediatrics (AAP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1999,12,1]]},"abstract":"<jats:sec><jats:title>Objective.<\/jats:title><jats:p>To evaluate the immunogenicity and reactogenicity of an acellular pertussis vaccine (pa) either formulated with diphtheria and tetanus toxoids (dTpa) or administered consecutively with a licensed tetanus and diphtheria vaccine (Td) as a 5th dose in adolescents.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods.<\/jats:title><jats:p>A total of 510 healthy children 10 to 13 years of age were assigned randomly, using a single-blind design, to receive either the dTpa vaccine or the Td vaccine with the pa vaccine 1 month later. The quantities of 3 pertussis antigens (pertussis toxin, filamentous hemagglutinin, and pertactin) in the dTpa and the pa vaccines were one third of those of the Infanrix vaccine (SmithKline Beecham Biologicals, Rixensart, Beligium) licensed for use in infants. For enzyme-linked immunosorbent assay measurement of serum immunoglobulin G antibodies and proliferation assay of peripheral blood mononuclear cells, blood samples were obtained before and 1 month after immunization. Local and systemic reactions were recorded on diary cards for 15 days after immunization.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results.<\/jats:title><jats:p>After immunization with dTpa or pa, significant and comparable rises in geometric mean values of antibodies (12- to 46-fold) and proliferations (8- to 18-fold) to each of the pertussis antigens were noted. After immunization with dTpa or Td, significant rises in geometric mean values of antidiphtheria and antitetanus antibodies (35- to 76-fold) were noted, and all subjects had values of these antibodies \u2265.1 international units\/mL. The dTpa and pa vaccines were at least as well tolerated as the licensed Td vaccine.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions.<\/jats:title><jats:p>Booster immunization of adolescents with an acellular vaccine containing reduced quantities of pertussis antigens in addition to diphtheria and tetanus toxoids induces good responses in both arms of the immune system without an increase in adverse reactions.<\/jats:p><\/jats:sec>","DOI":"10.1542\/peds.104.6.e70","type":"journal-article","created":{"date-parts":[[2004,8,13]],"date-time":"2004-08-13T23:45:45Z","timestamp":1092440745000},"page":"e70-e70","source":"Crossref","is-referenced-by-count":50,"title":["Acellular Vaccines Containing Reduced Quantities of Pertussis Antigens as a Booster in Adolescents"],"prefix":"10.1542","volume":"104","author":[{"given":"Nhu Nguyen Tran","family":"Minh","sequence":"first","affiliation":[{"name":"From the National Public Health Institute, Department in Turku,"},{"name":"Turku Immunology Center, the"},{"name":"Department of Pediatrics, Turku University Hospital, Turku, Finland; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiushui","family":"He","sequence":"additional","affiliation":[{"name":"From the National Public Health Institute, Department in Turku,"},{"name":"Turku Immunology Center, the"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anya","family":"Ramalho","sequence":"additional","affiliation":[{"name":"SmithKline Beecham Biologicals, Rixensart, Belgium."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Achim","family":"Kaufhold","sequence":"additional","affiliation":[{"name":"SmithKline Beecham Biologicals, Rixensart, Belgium."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matti K.","family":"Viljanen","sequence":"additional","affiliation":[{"name":"From the National Public Health Institute, Department in Turku,"},{"name":"Turku Immunology Center, the"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heikki","family":"Arvilommi","sequence":"additional","affiliation":[{"name":"From the National Public Health Institute, Department in Turku,"},{"name":"Turku Immunology Center, the"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jussi","family":"Mertsola","sequence":"additional","affiliation":[{"name":"From the National Public Health Institute, Department in Turku,"},{"name":"Turku Immunology Center, the"},{"name":"Department of Pediatrics, Turku University Hospital, Turku, Finland; and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[1999,12,1]]},"reference":[{"key":"2021121003105252700_B1"},{"key":"2021121003105252700_B2","first-page":"575","article-title":"Unrecognized pertussis infection in adolescents.","volume":"147","author":"Cromer","year":"1993","journal-title":"Am J Dis Child"},{"key":"2021121003105252700_B3","doi-asserted-by":"crossref","first-page":"522","DOI":"10.5694\/j.1326-5377.1987.tb120392.x","article-title":"Bordetella pertussis infection: a cause of persistent cough in adults.","volume":"147","author":"Robertson","year":"1987","journal-title":"Med J Aust"},{"key":"2021121003105252700_B4"},{"key":"2021121003105252700_B5","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/infdis\/170.4.873","article-title":"Outcomes of Bordetella pertussis infection in different age groups of an immunized population.","volume":"17","author":"He","year":"1994","journal-title":"J Infect Dis"},{"key":"2021121003105252700_B6","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1001\/archpedi.1978.02120290043006","article-title":"The changing epidemiology of pertussis in young infants: the role of adults as reservoirs of infection","volume":"132","author":"Nelson","year":"1978","journal-title":"Am J Dis Child"},{"key":"2021121003105252700_B7","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0022-3476(83)80403-X","article-title":"Intrafamilial spread of pertussis.","volume":"103","author":"Mertsola","year":"1983","journal-title":"J Pediatr"},{"key":"2021121003105252700_B8","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1093\/infdis\/161.3.480","article-title":"Widespread silent transmission of pertussis in families: antibody correlates of infection and symptomatology.","volume":"161","author":"Long","year":"1990","journal-title":"J Infect Dis"},{"key":"2021121003105252700_B9","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/clinids\/22.3.503","article-title":"Risk factors for pertussis in young infants during an outbreak in Chicago in 1993.","volume":"22","author":"Izurieta","year":"1996","journal-title":"Clin Infect Dis"},{"key":"2021121003105252700_B10","first-page":"1","article-title":"Diphtheria, tetanus, and pertussis: recommendations for vaccine use and other preventive measures.","volume":"40","author":"Immunization Practices Advisory Committee","year":"1991","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2021121003105252700_B11","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJM199602083340601","article-title":"A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis.","volume":"334","author":"Greco","year":"1996","journal-title":"N Engl J Med"},{"key":"2021121003105252700_B12","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/jama.1996.03530250041024","article-title":"Efficacy of acellular pertussis vaccine in early childhood after household exposure.","volume":"275","author":"Schmitt","year":"1996","journal-title":"JAMA"},{"key":"2021121003105252700_B13","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0264-410X(91)90267-A","article-title":"Development of an acellular pertussis vaccine and its administration as a booster in healthy adults.","volume":"9","author":"Ruuskanen","year":"1991","journal-title":"Vaccine"},{"key":"2021121003105252700_B14","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1001\/jama.1993.03500010063032","article-title":"Adult immunization with acellular pertussis vaccine.","volume":"269","author":"Edwards","year":"1993","journal-title":"JAMA"},{"key":"2021121003105252700_B15","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/BF01955054","article-title":"Acellular pertussis diphtheria-tetanus-pertussis vaccine containing separately purified pertussis toxoid, filamentous hemagglutinin and 69 kDa outer membrane protein as a booster in children.","volume":"152","author":"Kanra","year":"1993","journal-title":"Eur J Pediatr"},{"key":"2021121003105252700_B16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1542\/peds.93.1.37","article-title":"Acellular and whole-cell pertussis vaccines as a booster dose: a multicenter study.","volume":"93","author":"Englund","year":"1994","journal-title":"Pediatrics"},{"key":"2021121003105252700_B17","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1542\/peds.93.4.656","article-title":"Comparison of a three-component acellular pertussis vaccine with a whole-cell pertussis vaccine in 15- through 20-month-old infants.","volume":"93","author":"Bernstein","year":"1994","journal-title":"Pediatrics"},{"key":"2021121003105252700_B18","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1542\/peds.100.5.772","article-title":"A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old children.","volume":"100","author":"Pichichero","year":"1997","journal-title":"Pediatrics"},{"key":"2021121003105252700_B19","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S0022-3476(97)70247-6","article-title":"Reactogenicity and immunogenicity of a booster dose of a combined diphtheria, tetanus, and tricomponent acellular pertussis vaccine at fourteen to twenty-eight months of age.","volume":"130","author":"Schmitt","year":"1997","journal-title":"J Pediatr"},{"key":"2021121003105252700_B20","first-page":"253","article-title":"K, Ruuskanen O. Current status of pertussis and pertussis immunization in Finland.","volume":"14","author":"Mertsola, J., Viljanen, M","year":"1982","journal-title":"Ann Clin Res"},{"key":"2021121003105252700_B21","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1099\/00222615-25-4-279","article-title":"Estimation of Corynebacterium diphtheriae antitoxin in human sera: a comparison of an enzyme-linked immunosorbent assay with the toxin neutralisation test.","volume":"25","author":"Melville-Smith","year":"1988","journal-title":"J Med Microbiol"},{"key":"2021121003105252700_B22","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0092-1157(83)80038-9","article-title":"A comparison of enzyme-linked immunosorbent assay (ELISA) with the toxin neutralization test in mice as a method for the estimation of tetanus antitoxin in human sera.","volume":"11","author":"Melville-Smith","year":"1983","journal-title":"J Biol Stand"},{"key":"2021121003105252700_B23","doi-asserted-by":"crossref","first-page":"3796","DOI":"10.1128\/IAI.66.8.3796-3801.1998","article-title":"Cytokine mRNA expression and proliferative responses induced by pertussis toxin, filamentous hemagglutinin, and pertactin of Bordetella pertussis in the peripheral blood mononuclear cells of infected and immunized schoolchildren and adults.","volume":"66","author":"He","year":"1998","journal-title":"Infect Immun"},{"key":"2021121003105252700_B24","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1001\/archpedi.1997.02170400069013","article-title":"Cell-mediated and antibody responses to Bordetella pertussis antigens in children vaccinated with acellular or whole-cell pertussis vaccines.","volume":"151","author":"Cassone","year":"1997","journal-title":"Arch Pediatr Adolesc Med"},{"key":"2021121003105252700_B25"},{"key":"2021121003105252700_B26","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1128\/iai.64.10.4078-4084.1996","article-title":"Pertussis-specific cell-mediated immunity in infants after immunization with a tricomponent acellular pertussis vaccine.","volume":"64","author":"Zepp","year":"1996","journal-title":"Infect Immun"},{"key":"2021121003105252700_B27","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/S0264-410X(98)00072-3","article-title":"Antibody and cell-mediated immune responses to booster immunization with a new acellular pertussis vaccine in school children.","volume":"16","author":"Tran Minh NN, Edelman K, He Q, Viljanen MK, Arvilommi H, Mertsola J","year":"1998","journal-title":"Vaccine"},{"key":"2021121003105252700_B28","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2307\/4592424","article-title":"Epidemiology of a small pertussis outbreak in Kent County, Michigan.","volume":"80","author":"Lambert","year":"1965","journal-title":"Public Health Rep"},{"key":"2021121003105252700_B29","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1136\/bmj.296.6622.612","article-title":"Duration of effectiveness of pertussis vaccine: evidence from a 10 year community study study.","volume":"296","author":"Jenkinson","year":"1986","journal-title":"Br Med J"},{"key":"2021121003105252700_B30","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/00006454-199904000-00011","article-title":"A ten year follow-up after immunization with a two component acellular pertussis vaccine.","volume":"18","author":"Tindberg","year":"1999","journal-title":"Pediatr Infect Dis J"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/104\/6\/e70\/886941\/pe1299000f1p.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/104\/6\/e70\/886941\/pe1299000f1p.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T07:32:56Z","timestamp":1734507176000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/104\/6\/e70\/62730\/Acellular-Vaccines-Containing-Reduced-Quantities"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,12,1]]},"references-count":30,"journal-issue":{"issue":"6","published-online":{"date-parts":[[1999,12,1]]},"published-print":{"date-parts":[[1999,12,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.104.6.e70","relation":{},"ISSN":["1098-4275","0031-4005"],"issn-type":[{"value":"1098-4275","type":"electronic"},{"value":"0031-4005","type":"print"}],"subject":[],"published":{"date-parts":[[1999,12,1]]}}}